TY - JOUR
T1 - Comparative Tumorigenicity of 1-Nitropyrene, 1-Nitrosopyrene, and 1-Aminopyrene Administered by Gavage to Sprague-Dawley Rats
AU - El-Bayoumy, Karam
AU - Rivenson, Abraham
AU - Johnson, Bruce
AU - DiBello, Joann
AU - Little, Patricia
AU - Hecht, Stephen S.
PY - 1988
Y1 - 1988
N2 - The carcinogenic activities of 1-nitropyrene, a mutagenic component of diesel exhaust, and its reduced derivatives 1-nitrosopyrene and 1-aminopyrene were evaluated in male and female Sprague-Dawley rats. Within 24 h of birth, groups of 22–36 rats were treated by gavage with trioctanoin or the appropriate compound in trioctanoin once weekly for 16 weeks. The approximate total doses per rat were as follows: 1-nitropyrene, high dose (800 μmol); 1-nitropyrene, low dose (320 μmol); 1-nitrosopyrene (320 μmol); 1-aminopyrene (320 μmol). The experiment was terminated after 94 weeks. The main site of tumor induction was the mammary glands of female rats. Percentages of incidences of mammary adenocarcinomas in female rats were as follows: 1-nitropyrene, high dose (63%); 1-nitropyrene, low dose (42%); 1-nitrosopyrene (19%); 1-aminopyrene (4%); trioctanoin (3%). These incidences were significantly greater than those of controls for the female rats treated with either 1-nitropyrene or 1-nitrosopyrene. Low and generally insignificant incidences of tumors of a variety of other sites were also observed in rats treated with 1-nitropyrene. The induction of mammary tumors by 1-nitropyrene confirms the results of a previous study (Hirose et al., Cancer Res., 44: 1158–1162, 1984). The present results also demonstrate that, under the conditions of this bioassay, 1-nitropyrene was significantly more carcinogenic than either 1-nitrosopyrene or 1-aminopyrene.
AB - The carcinogenic activities of 1-nitropyrene, a mutagenic component of diesel exhaust, and its reduced derivatives 1-nitrosopyrene and 1-aminopyrene were evaluated in male and female Sprague-Dawley rats. Within 24 h of birth, groups of 22–36 rats were treated by gavage with trioctanoin or the appropriate compound in trioctanoin once weekly for 16 weeks. The approximate total doses per rat were as follows: 1-nitropyrene, high dose (800 μmol); 1-nitropyrene, low dose (320 μmol); 1-nitrosopyrene (320 μmol); 1-aminopyrene (320 μmol). The experiment was terminated after 94 weeks. The main site of tumor induction was the mammary glands of female rats. Percentages of incidences of mammary adenocarcinomas in female rats were as follows: 1-nitropyrene, high dose (63%); 1-nitropyrene, low dose (42%); 1-nitrosopyrene (19%); 1-aminopyrene (4%); trioctanoin (3%). These incidences were significantly greater than those of controls for the female rats treated with either 1-nitropyrene or 1-nitrosopyrene. Low and generally insignificant incidences of tumors of a variety of other sites were also observed in rats treated with 1-nitropyrene. The induction of mammary tumors by 1-nitropyrene confirms the results of a previous study (Hirose et al., Cancer Res., 44: 1158–1162, 1984). The present results also demonstrate that, under the conditions of this bioassay, 1-nitropyrene was significantly more carcinogenic than either 1-nitrosopyrene or 1-aminopyrene.
UR - http://www.scopus.com/inward/record.url?scp=0023761110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023761110&partnerID=8YFLogxK
M3 - Article
C2 - 3390821
AN - SCOPUS:0023761110
SN - 0008-5472
VL - 48
SP - 4256
EP - 4260
JO - Cancer Research
JF - Cancer Research
IS - 15
ER -